Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonFree Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activities
Growth Metrics
Income Statement
Others
Ratios

Selectis Health (GBCS) Change in Cash (2017 - 2025)

Historic Change in Cash for Selectis Health (GBCS) over the last 14 years, with Q3 2025 value amounting to -$107912.0.

  • Selectis Health's Change in Cash rose 9509.65% to -$107912.0 in Q3 2025 from the same period last year, while for Sep 2025 it was -$598585.0, marking a year-over-year increase of 5206.65%. This contributed to the annual value of -$912757.0 for FY2024, which is 71585.76% down from last year.
  • As of Q3 2025, Selectis Health's Change in Cash stood at -$107912.0, which was up 9509.65% from -$693775.0 recorded in Q2 2025.
  • Selectis Health's Change in Cash's 5-year high stood at $2.0 million during Q2 2024, with a 5-year trough of -$2.2 million in Q3 2024.
  • Its 5-year average for Change in Cash is -$144962.7, with a median of -$216857.0 in 2023.
  • Over the last 5 years, Selectis Health's Change in Cash had its largest YoY gain of 75830.55% in 2022, and its largest YoY loss of 146234.04% in 2022.
  • Over the past 5 years, Selectis Health's Change in Cash (Quarter) stood at $1.2 million in 2021, then tumbled by 129.13% to -$343559.0 in 2022, then tumbled by 123.15% to -$766656.0 in 2023, then skyrocketed by 43.83% to -$430630.0 in 2024, then soared by 74.94% to -$107912.0 in 2025.
  • Its Change in Cash stands at -$107912.0 for Q3 2025, versus -$693775.0 for Q2 2025 and $633732.0 for Q1 2025.